J. Reinglas, K. Amjadi, and B. Petrcich, The palliative management of refractory cirrhotic ascites using the PleurX catheter, Can J Gastroenterol Hepatol, vol.2016, p.4680543, 2016.

F. Anatomie-du,

.. .. Centre-hépatobiliaire-paul-brousse,

J. Villanueva, Place du sovaldi dans le traitement de l'hépatite C chronique de l'adulte

D. Adebayo, S. Neong, and F. Wong, Refractory Ascites in Liver Cirrhosis.The American Journal of Gastroenterology, vol.114, pp.40-47, 2019.

F. Morando, S. Rosi, and E. Gola, Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites : a real life cross section al study, Hepatology, vol.35, pp.1535-1542, 2006.

E. Evans and T. , Review article : albumin as a drug : biological effects of albumin unrelated to oncotic pressure, Aliment pharmacol Ther, vol.16, pp.6-11, 2002.

A. Mattos and . Machadosb,

. Balle and V. V. Vr-e-dominguez, Sobrebida de patientes cirroticos com ascite, GED, vol.17, pp.17-21, 1998.

, Etude Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis, Gastroenterology, vol.111, pp.1002-1012, 1996.

, 30 Infeccion bacteriana no paciente cirrotico, Guide de bonnes pratiques de l'AASLD (American Association for the Study of Liver Disease), vol.40, pp.11-15, 2003.

F. Salerno, A. Gerbes, P. Ginès, and V. Arroyo, Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis, Gut, vol.56, pp.1310-1318, 2007.

. .. Vidal, 34 Terlipressin therapy with and without albumin for patients with hepatorenal syndrome : results of a prospective, non randomized study, Hepatology, vol.36, pp.941-949, 2002.

. .. Vidal,

. Morando, 38 Refractory ascites in Liver Cirrhosis, Danielle Adebayo, Am J Gastroenterol

R. Moreau, D. Valla, and D. , Comparison of outcome in patients with albumin or a synthetic colloid : a randomised controlled pilot trial, Liver Int, vol.26, pp.46-54, 2006.

T. T. Guo and Y. Yang, Effects of midodrine in patients with ascites due to cirrhosis : systematic review and meta-analysis, J Dig Dis, vol.17, pp.11-19, 2016.

, Rev Med Suisse, vol.10, pp.1607-1618, 2014.

, 41 Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage, Gastroenterology, vol.10, issue.4, pp.41-49, 2001.

H. K. Tan, P. D. James, and K. W. Sniderman, Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with TIPS insertion, J Gastroenterol Hepatol, 2015.

. Russo, A. Sood, and I. Jacobson, Transjugular hepatic portosystemic shunt for refractory ascites : an analysis of the literature on efficacity, morbidity and mortality, Am J Gastroenteral, vol.98, pp.2521-2528, 2003.

C. Bureau, D. Thabut, and F. Oberti, Transjugular intrahepatic portosystemic shunts with covered stents increase transplant free survival of patients with cirrhosis and recurrent ascites, Gastroenterology, vol.152, pp.157-63, 2017.